Quality of Life Assessment in Patients with Idiopathic and Inducible Chronic Urticaria

Sara Sarwar; Sakina Sadiq Malik; Naveed Akhtar Malik; Muhammad Waseem Shahid; Aleena Nasir; Samina

doi:10.51253/pafmj.v76iSUPPL-5.13056

Authors

Sara Sarwar Department of Dermatology, Pakistan Emirates Military Hospital, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Sakina Sadiq Malik Department of Dermatology, Pakistan Emirates Military Hospital, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Naveed Akhtar Malik Department of Dermatology, Pakistan Emirates Military Hospital, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Muhammad Waseem Shahid Department of Dermatology, Pakistan Emirates Military Hospital, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Aleena Nasir Department of Dermatology, Pakistan Emirates Military Hospital, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
Samina Department of Dermatology, Pakistan Emirates Military Hospital, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v76iSUPPL-5.13056

Keywords:

Chronic urticaria, Dermatology Life Quality Index, Idiopathic CU, Inducible CU.

Abstract

Objective: To determine impact on quality of life (QoL) in patients of Chronic Urticaria (CU) and to compare it between Idiopathic and Inducible Chronic Urticaria.

Study Design: Cross-sectional study.

Place and Duration of Study: Department of Dermatology, Pakistan Emirates Military Hospital, Rawalpindi, Pakistan over a period of four months starting from Sep to Dec 2024.

Methodology: A total of 150 patients were recruited for this study. The quality of life was noted as per operational definition of Dermatology Life Quality Index (DLQI). Data was analyzed using Statistical Package for the Social Sciences (SPSS.25). Descriptive statistics were calculated for both qualitative and quantitative variables.

Result: The mean age of participants was 41.1±18.0 years, with a female predominance. The data were normally distributed. Subtypes of urticaria were as follows: Idiopathic urticaria 84(56%) and inducible urticaria 66(44%). Quality of life was affected in both subtypes; however, the difference between them was not statistically significant.

Conclusion: This study confers that chronic urticaria has a huge effect on the quality of life in chronic urticaria patients along with significant psycho-social limitations. The effect on quality of life was found to be higher in idiopathic urticaria as compared to inducible urticaria, but statistically insignificant.

Downloads

Download data is not yet available.

References

Almeida AR, Oliveiros B, Gonçalo M. Relation between Chronic Urticaria and Quality of Life: An Observational Study of 112 Portuguese Patients. J Port Soc Dermatology Venereol 2021; 79(3): 233–240.

https://doi.org/10.29021/spdv.79.3.1402

2. Sánchez-Borges M, Ansotegui IJ, Baiardini I, Bernstein J, Canonica GW, Ebisawa M, et al. The challenges of chronic urticaria part 1: Epidemiology, immunopathogenesis, comorbidities, quality of life, and management. World Allergy Organ J 2021; 14(6): 100533.

https://doi.org/10.1016/j.waojou.2021.100533

3. Giordano-Labadie F, Becherel PA, Pralong P, Outtas O, Ruer-Mulard M, Berard F, et al. Improvement of patient outcomes following therapeutic optimization of chronic urticaria: two-year data from France as part of the international real-life AWARE study. Eur J Dermatol 2021; 31(2): 217–224.

https://doi.org/10.1684/ejd.2021.4023

4. Gonçalo M, Gimenéz-Arnau A, Al-Ahmad M, Ben-Shoshan M, Bernstein JA, Ensina LF, et al. The global burden of chronic urticaria for the patient and society*. Br J Dermatol 2021; 184(2): 226–236.

https://doi.org/10.1111/bjd.19561

5. Muñoz M, Kiefer LA, Pereira MP, Bizjak M, Maurer M. New insights into chronic inducible urticaria. Curr Allergy Asthma Rep 2024; 24(8): 457–469.

https://doi.org/10.1007/s11882-024-01160-y

6. Cherrez-Ojeda I, Maurer M, Felix M, Bernstein JA, Ramon GD, Jardim Criado RF, et al. “Chronic urticaria and obstructive sleep apnea: Is there a significant association?” World Allergy Organ J 2021; 14(8): 100577.

https://doi.org/10.1016/j.waojou.2021.100577

7. Giménez-Arnau AM, Manzanares N, Podder I. Recent updates in urticaria. Med Clin 2023; 161(10): 435–444.

https://doi.org/10.1016/j.medcli.2023.06.026

8. Paudel S, Parajuli N, Sharma RP, Dahal S, Paudel S. Chronic urticaria and its impact on the quality of life of Nepalese patients. Dermatol Res Pract 2020; 2020(1): 6694191.

https://doi.org/10.1155/2020/6694191

9. Rees H, Wall D, Bokhari L, Asfour L, Sinclair R. Reliability and validity of a measure to assess the health-related quality of life of women with alopecia areata. Clin Exp Dermatol 2023; 48(6): 681–684.

https://doi.org/10.1093/ced/llad066

10. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19(3): 210-216.

https://doi:10.1111/j.1365-2230.1994.tb01167.x

11. Min J, Her Y, Moon KW, Park JI, Kim S, Cho EH, et al. Assessing Quality of Life in Patients with Chronic Urticaria Through Comparisons With Patients Having Other Common Chronic Diseases. J Allergy Clin Immunol Pract 2023; 11(8): 2426-2431.

https://doi.org/10.1016/j.jaip.2023.03.047

12. Ates H, Firat S, Buhari GK, Keren M, Cifci B, Erkekol FÖ et al. Relationships between quality of life, sleep problems, and sleep quality in patients with chronic idiopathic urticaria. J Cosmet Dermatol 2022; 21(9): 4072-4079.

https://doi.org/10.1111/jocd.14851

13. Silvares MRC, Fortes MRP, Miot HA. Quality of life in chronic urticaria: A survey at a public university outpatient clinic, Botucatu (Brazil). Rev Assoc Med Bras 2011; 57(5): 565–569.

https://doi.org/10.1016/s0104-4230(11)70114-2

14. Stadler PC, Marsela E, Kämmerer T, Frommherz LH, Clanner-Engelshofen B, French LE, et al. Impact of allergic reactions and urticaria on mental health and quality of life. Allergol Immunopathol 2022; 50(2): 124–130.

https://doi.org/10.15586/aei.v50i2.525

15. Weller K, Church MK, Kalogeromitros D. Chronic Spontaneous Urticaria: How to Assess Quality of Life in Patients Receiving Treatment. Arch Dermatol 2011; 147(10): 1221–1223.

https://doi:10.1001/archdermatol.2011.310

16. Abdel-Meguid AM, Awad SM, Noaman M, Abdel Gawad AM, Abou-Taleb DAE. Does chronic urticaria affect quality of sleep and quality of life? J Public health Res 2024; 13(2): 22799036241243268. https://doi.org/10.1177/22799036241243268

17. Itakura A, Tani Y, Kaneko N, Hide M. Impact of chronic urticaria on quality of life and work in Japan: Results of a real-world study. J Dermatol 2018; 45(8): 963–970.

https://doi.org/10.1111/1346-8138.14502

18. Maurer M, Giménez-Arnau A, Ensina LF, Chu CY, Jaumont X, Tassinari P. Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results. World Allergy Organ J 2020; 13(9): 100460.

https://doi:10.1016/j.waojou.2020.100460

19. Chen J, Ou S, Wu W, Zou H, Li H, Zhu H. Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study on Effectiveness, Safety and Predictors of Treatment Outcome. Clin Cosmet Investig Dermatol 2024; 17: 1799–1808.

https://doi.org/10.2147/CCID.S470160